PBCRF(PBCRF)
PBCRF
No analyst ratings available
No analyst price targets available for PBCRF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $116.36T | $125.36T | $135.02T |
| Low | $113.01T | $119.69T | $129.98T |
| High | $123.78T | $135.28T | $144.71T |
| EBITDA Avg | $83.23T | $89.68T | $96.58T |
| Low | $80.84T | $85.61T | $92.97T |
| High | $88.54T | $96.77T | $103.51T |
| EBIT Avg | $81.74T | $88.07T | $94.85T |
| Low | $79.39T | $84.08T | $91.30T |
| High | $86.95T | $95.03T | $101.65T |
| Net Income Avg | $59.53T | $64.76T | $70.87T |
| Low | $56.64T | $61.62T | $67.42T |
| High | $65.08T | $70.80T | $77.48T |
| EPS Avg | $482.92 | $525.36 | $574.87 |
| Low | $459.46 | $499.84 | $546.94 |
| High | $527.96 | $574.36 | $628.48 |
| Analysts (Rev / EPS) | 19 / 1 | 20 / 1 | 10 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $28.81T | $30.10T | $30.51T |
| Low | $28.81T | $30.10T | $30.51T |
| High | $28.81T | $30.10T | $30.51T |
| EBITDA Avg | $20.61T | $21.53T | $21.82T |
| Low | $20.61T | $21.53T | $21.82T |
| High | $20.61T | $21.53T | $21.82T |
| EBIT Avg | $20.24T | $21.15T | $21.43T |
| Low | $20.24T | $21.15T | $21.43T |
| High | $20.24T | $21.15T | $21.43T |
| Net Income Avg | $877M | $865M | $968M |
| Low | $877M | $865M | $968M |
| High | $877M | $865M | $968M |
| EPS Avg | $120.94 | $119.26 | $133.43 |
| Low | $120.94 | $119.26 | $133.43 |
| High | $120.94 | $119.26 | $133.43 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |